Psoriasis
News
New Evidence Defines Optimal Methotrexate Dosing Regimen in Psoriasis
Major Finding: Patients who show a good response to methotrexate 15 mg/week by week 6-8 have a high probability of having a full PASI 75 response...
News
Methotrexate, Cyclosporine Present Unique Clinical Challenges
News
Comorbidities Are Common in Lupus
News
Tonsillectomy Reduces Strep-Triggered Psoriasis
Major Finding: Thirteen of 15 tonsillectomy patients showed significant improvement, with reductions of 30%-90% in PASI scores during 2 years of...
News
Sandoz Voluntarily Recalls All Methotrexate Lots
News
EADV: Patients Often Unaware of Infliximab Infusion Risk
Major Finding: In 22% of instances of cancelled infusion, patients came to the clinic for their infusion unaware that their health status at that...
News
Expert Panel: Switch Methotrexate Nonresponders to Subcutaneous Form
News
AMG 827 Trial Participants Show Improvement of Chronic Plaque Psoriasis
Major Finding: PASI 75 was achieved by day 43 in five of eight patients who received 350 mg AMG 827, in seven of eight who got 700 mg, and none of...
News
EADV: Study Points to Optimal Etanercept Regimen for Psoriasis, PsA
Major Finding: After 24 weeks of etanercept therapy, dactylitis scores had improved by a mean of 85%, compared with baseline, while enthesis...
News
EADV: Implant Reduced Phototoxic Attacks in Erythropoietic Protoporphyria
Major Finding: During the active-treatment periods, more than half of patients reported spending greater than 6 hours per day outdoors while...